Publication Cover
Xenobiotica
the fate of foreign compounds in biological systems
Volume 42, 2012 - Issue 10
1,025
Views
51
CrossRef citations to date
0
Altmetric
General Xenobiochemistry

Generation of proliferating human hepatocytes using upcyte® technology: characterisation and applications in induction and cytotoxicity assays

, , , , , , , & show all
Pages 939-956 | Received 13 Jan 2012, Accepted 08 Mar 2012, Published online: 24 Apr 2012

References

  • Arlotto MP, Trant JM, Estabrook RW. (1991). Measurement of steroid hydroxylation reactions by high-performance liquid chromatography as indicator of P450 identity and function. Meth Enzymol 206:454–462.
  • Bokhari M, Carnachan RJ, Cameron NR, Przyborski SA. (2007). Novel cell culture device enabling three-dimensional cell growth and improved cell function. Biochem Biophys Res Commun 354:1095–1100.
  • Bokhari M, Carnachan RJ, Cameron NR, Przyborski SA. (2007b). Culture of HepG2 liver cells on three dimensional polystyrene scaffolds enhances cell structure and function during toxicological challenge. J Anat 211:567–576.
  • Björnsson E. (2008). Hepatotoxicity associated with antiepileptic drugs. Acta Neurol Scand 118:281–290.
  • Braspenning J, Holder S, Kuepper H. (2010). Propagation of primary cells and use therof. Patent EP2185690:05–19.
  • Campard D, Lysy PA, Najimi M, Sokal EM. (2008). Native umbilical cord matrix stem cells express hepatic markers and differentiate into hepatocyte-like cells. Gastroenterology 134:833–848.
  • Castell JV, Jover R, Martínez-Jiménez CP, Gómez-Lechón MJ. (2006). Hepatocyte cell lines: Their use, scope and limitations in drug metabolism studies. Expert Opin Drug Metab Toxicol 2:183–212.
  • Delgado JP, Parouchev A, Allain JE, Pennarun G, Gauthier LR, Dutrillaux AM, Dutrillaux B, Di Santo J, Capron F, Boussin FD, Weber A. (2005). Long-term controlled immortalization of a primate hepatic progenitor cell line after Simian virus 40 T-Antigen gene transfer. Oncogene 24:541–551.
  • Duret C, Gerbal-Chaloin S, Ramos J, Fabre JM, Jacquet E, Navarro F, Blanc P, Sa-Cunha A, Maurel P, Daujat-Chavanieu M. (2007). Isolation, characterization, and differentiation to hepatocyte-like cells of nonparenchymal epithelial cells from adult human liver. Stem Cells 25:1779–1790.
  • Ekins S, Murray GI, Burke MD, Williams JA, Marchant NC, Hawksworth GM. (1995). Quantitative differences in phase I and II metabolism between rat precision-cut liver slices and isolated hepatocytes. Drug Metab Dispos 23:1274–1279.
  • Ellouk-Achard S, Martin C, Pham-Huy C, Duc HT, Thevenin M, Dutertre-Catella H, Warnet JM, Claude JR. (1997). Implication of CYP 3A in the toxicity of cyclosporin G (CsG), cyclosporin A (CsA) and FK506 on rat hepatocytes in primary culture. Arch Toxicol 71:437–442.
  • Fabre N, Arrivet E, Trancard J, Bichet N, Roome NO, Prenez A, Vericat JA. (2003). A new hepatoma cell line for toxicity testing at repeated doses. Cell Biol Toxicol 19:71–82.
  • Fahmi OA, Boldt S, Kish M, Obach RS, Tremaine LM. (2008). Prediction of drug-drug interactions from in vitro induction data: Application of the relative induction score approach using cryopreserved human hepatocytes. Drug Metab Dispos 36:1971–1974.
  • Fausto N. (2004). Liver regeneration and repair: Hepatocytes, progenitor cells, and stem cells. Hepatology 39:1477–1487.
  • Gómez-Lechón MJ, López P, Donato T, Montoya A, Larrauri A, Giménez P, Trullenque R, Fabra R, Castell JV. (1990). Culture of human hepatocytes from small surgical liver biopsies. Biochemical characterization and comparison with in vivo. In Vitro Cell Dev Biol 26:67–74.
  • Habig WH, Pabst MJ, Jakoby WB. (1974). Glutathione S-transferases. The first enzymatic step in mercapturic acid formation. J Biol Chem 249:7130–7139.
  • Hashemi SM, Soleimani M, Zargarian SS, Haddadi-Asl V, Ahmadbeigi N, Soudi S, Gheisari Y, Hajarizadeh A, Mohammadi Y. (2009). In vitro differentiation of human cord blood-derived unrestricted somatic stem cells into hepatocyte-like cells on poly(epsilon-caprolactone) nanofiber scaffolds. Cells Tissues Organs (Print) 190:135–149.
  • Hengstler JG, Ringel M, Biefang K, Hammel S, Milbert U, Gerl M, Klebach M, Diener B, Platt KL, Böttger T, Steinberg P, Oesch F. (2000). Cultures with cryopreserved hepatocytes: Applicability for studies of enzyme induction. Chem Biol Interact 125:51–73.
  • Herrera MB, Bruno S, Buttiglieri S, Tetta C, Gatti S, Deregibus MC, Bussolati B, Camussi G. (2006). Isolation and characterization of a stem cell population from adult human liver. Stem Cells 24:2840–2850.
  • Hewitt NJ, Lloyd S, Hayden M, Butler R, Sakai Y, Springer R, Fackett A, Li AP. (2002). Correlation between troglitazone cytotoxicity and drug metabolic enzyme activities in cryopreserved human hepatocytes. Chem Biol Interact 142:73–82.
  • Hewitt NJ, Lechón MJ, Houston JB, Hallifax D, Brown HS, Maurel P, Kenna JG, Gustavsson L, Lohmann C, Skonberg C, Guillouzo A, Tuschl G, Li AP, LeCluyse E, Groothuis GM, Hengstler JG. (2007). Primary hepatocytes: Current understanding of the regulation of metabolic enzymes and transporter proteins, and pharmaceutical practice for the use of hepatocytes in metabolism, enzyme induction, transporter, clearance, and hepatotoxicity studies. Drug Metab Rev 39:159–234.
  • Kern A, Bader A, Pichlmayr R, Sewing KF. (1997). Drug metabolism in hepatocyte sandwich cultures of rats and humans. Biochem Pharmacol 54:761–772.
  • Khuu DN, Najimi M, Sokal EM. (2007). Epithelial cells with hepatobiliary phenotype: Is it another stem cell candidate for healthy adult human liver? World J Gastroenterol 13:1554–1560.
  • Letschert K, Faulstich H, Keller D, Keppler D. (2006). Molecular characterization and inhibition of amanitin uptake into human hepatocytes. Toxicol Sci 91:140–149.
  • Li AP. (2007). Human hepatocytes: Isolation, cryopreservation and applications in drug development. Chem Biol Interact 168:16–29.
  • Li AP. (2009). Metabolism Comparative Cytotoxicity Assay (MCCA) and Cytotoxic Metabolic Pathway Identification Assay (CMPIA) with cryopreserved human hepatocytes for the evaluation of metabolism-based cytotoxicity in vitro: Proof-of-concept study with aflatoxin B1. Chem Biol Interact 179:4–8.
  • Lian G, Wang C, Teng C, Zhang C, Du L, Zhong Q, Miao C, Ding M, Deng H. (2006). Failure of hepatocyte marker-expressing hematopoietic progenitor cells to efficiently convert into hepatocytes in vitro. Exp Hematol 34:348–358.
  • Liu C, Schreiter T, Dirsch O, Gerken G, Oldhafer KJ, Broelsch CE, Treichel U. (2004). Presence of markers for liver progenitor cells in human-derived intrahepatic biliary epithelial cells. Liver Int 24:669–678.
  • Livak KJ, Schmittgen TD. (2001). Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25:402–408.
  • Makhlouf HA, Helmy A, Fawzy E, El-Attar M, Rashed HA. (2008). A prospective study of antituberculous drug-induced hepatotoxicity in an area endemic for liver diseases. Hepatol Int 2:353–360.
  • Maurel P. (1996). The use of adult human hepatocytes in primary culture and other in vitro systems to investigate drug metabolism in man. Adv Drug Deliv Rev 22:105–132.
  • Raucy JL, Lasker J, Ozaki K, Zoleta V. (2004). Regulation of CYP2E1 by ethanol and palmitic acid and CYP4A11 by clofibrate in primary cultures of human hepatocytes. Toxicol Sci 79:233–241.
  • Ripp SL, Mills JB, Fahmi OA, Trevena KA, Liras JL, Maurer TS, de Morais SM. (2006). Use of immortalized human hepatocytes to predict the magnitude of clinical drug-drug interactions caused by CYP3A4 induction. Drug Metab Dispos 34:1742–1748.
  • Sahi J, Black CB, Hamilton GA, Zheng X, Jolley S, Rose KA, Gilbert D, LeCluyse EL, Sinz MW. (2003). Comparative effects of thiazolidinediones on in vitro P450 enzyme induction and inhibition. Drug Metab Dispos 31:439–446.
  • Schutte M, Fox B, Baradez MO, Devonshire A, Minguez J, Bokhari M, Przyborski S, Marshall D. (2011). Rat primary hepatocytes show enhanced performance and sensitivity to acetaminophen during three-dimensional culture on a polystyrene scaffold designed for routine use. Assay Drug Dev Technol 9:475–486.
  • Selden C, Chalmers SA, Jones C, Standish R, Quaglia A, Rolando N, Burroughs AK, Rolles K, Dhillon A, Hodgson HJ. (2003). Epithelial colonies cultured from human explanted liver in subacute hepatic failure exhibit hepatocyte, biliary epithelial, and stem cell phenotypic markers. Stem Cells 21:624–631.
  • Selim K, Kaplowitz N. (1999). Hepatotoxicity of psychotropic drugs. Hepatology 29:1347–1351.
  • Shehab N, Patel PR, Srinivasan A, Budnitz DS. (2008). Emergency department visits for antibiotic-associated adverse events. Clin Infect Dis 47:735–743.
  • Shen C, Cheng X, Li D, Meng Q. (2009). Investigation of rifampicin-induced hepatotoxicity in rat hepatocytes maintained in gel entrapment culture. Cell Biol Toxicol 25:265–274.
  • Tilghman SM. (1985). The structure and regulation of the alpha-fetoprotein and albumin genes. Oxf Surv Eukaryot Genes 2:160–206.
  • Tsuji T, Miyazaki M, Sakaguchi M, Inoue Y, Namba M. (2000). A REIC gene shows down-regulation in human immortalized cells and human tumor-derived cell lines. Biochem Biophys Res Commun 268:20–24.
  • Upmanyu R, Dvivedi J, Saxena Y. (2009). Hepatotoxic effects of vincristine: An experimental study on albino rats. Indian J Physiol Pharmacol 53:265–270.
  • Wang K, Shindoh H, Inoue T, Horii I. (2002). Advantages of in vitro cytotoxicity testing by using primary rat hepatocytes in comparison with established cell lines. J Toxicol Sci 27:229–237.
  • Xie Z, Zhang H, Tsai W, Zhang Y, Du Y, Zhong J, Szpirer C, Zhu M, Cao X, Barton MC, Grusby MJ, Zhang WJ. (2008). Zinc finger protein ZBTB20 is a key repressor of alpha-fetoprotein gene transcription in liver. Proc Natl Acad Sci USA 105:10859–10864.
  • Xu J, Ma M, Purcell WM. (2003). Characterisation of some cytotoxic endpoints using rat liver and HepG2 spheroids as in vitro models and their application in hepatotoxicity studies. I. Glucose metabolism and enzyme release as cytotoxic markers. Toxicol Appl Pharmacol 189:100–111.
  • Yamazaki H, Inoue K, Mimura M, Oda Y, Guengerich FP, Shimada T. (1996). 7-Ethoxycoumarin O-deethylation catalyzed by cytochromes P450 1A2 and 2E1 in human liver microsomes. Biochem Pharmacol 51:313–319.
  • Yang XX, Hu ZP, Xu AL, Duan W, Zhu YZ, Huang M, Sheu FS, Zhang Q, Bian JS, Chan E, Li X, Wang JC, Zhou SF. (2006). A mechanistic study on reduced toxicity of irinotecan by coadministered thalidomide, a tumor necrosis factor-alpha inhibitor. J Pharmacol Exp Ther 319:82–104.
  • Yang Z, Fong DW, Yin L, Wong Y, Huang W. (2009). Liposomes modulate docetaxel-induced lipid oxidization and membrane damage in human hepatoma cells. J Liposome Res 19:122–130.
  • Yin J, Meng Q, Zhang G, Sun Y. (2009). Differential methotrexate hepatotoxicity on rat hepatocytes in 2-D monolayer culture and 3-D gel entrapment culture. Chem Biol Interact 180:368–375.
  • Zhang L, Mu X, Fu J, Zhou Z. (2007). In vitro cytotoxicity assay with selected chemicals using human cells to predict target-organ toxicity of liver and kidney. Toxicol In Vitro 21:734–740.
  • Ziegler HK, Sinazadeh M. (1975). [Anticonvulsant drugs and liver damage (Author’s transl)]. J Neurol 208:207–220.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.